Blue Owl Capital Inc. has purchased a portfolio of private hospitals in the UK from Malaysia’s Employees Provident Fund [1, 2].

The transaction represents a significant shift in healthcare infrastructure ownership, as a major Malaysian sovereign wealth fund exits its position in the British private medical market. This move highlights the ongoing trend of private equity and capital firms acquiring essential health services to optimize operational efficiencies.

The deal was valued at £1.3 billion [1, 2]. Bloomberg said, "Blue Owl Capital Inc has completed a deal to buy a portfolio of UK private hospitals from Malaysia’s Employees Provident Fund" [1].

The acquisition was driven by the Employees Provident Fund's decision to divest its holdings in the UK private hospital sector [1, 2]. This strategic exit allows the Malaysian fund to reallocate capital toward other global investments while Blue Owl expands its footprint in the European healthcare landscape.

The Star said the transaction was finalized on July 8, 2026 [2]. The purchase includes multiple facilities across the UK, though the specific number of hospitals was not detailed in the reports [1, 2].

Blue Owl Capital has not provided further details on the intended operational changes for the hospitals, but the firm typically focuses on scaling assets through disciplined capital management. The deal marks one of the largest recent transfers of private healthcare assets in the region [1, 2].

“Blue Owl Capital Inc. has purchased a portfolio of private hospitals in the UK from Malaysia’s Employees Provident Fund”

This acquisition signals a broader trend of institutional capital rotating out of direct healthcare ownership in the UK. As the Employees Provident Fund divests, the entry of Blue Owl Capital suggests a shift toward a more aggressive, private-equity-led management style for these facilities. This could lead to increased consolidation in the UK private health sector, potentially impacting how these hospitals interface with the National Health Service (NHS) and private insurance providers.